关键词：生物试剂；检测；化学化合物；分子生物技术；研究领域
摘 要：This report covers the present scenario and growth prospects of the Global Biotechnology Reagents market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from two major segments: Life Science and Analytics.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Technology

07.1.1 Life Science

07.1.2 Analytical

08. Global Chromatography Reagents

Market

08.1 Market Overview

08.1.1 Market Size and Forecast

09. Global IVD Reagents Market

09.1 Market Overview

09.1.1 Market Size and Forecast

10. Global PCR Reagents Market

10.1.1 Market Size and Forecast

11. Global Flow Cytometry Reagents Market

11.1 Market Overview

11.1.1 Market Size and Forecast

12. Global Cell Culture Reagents Market

12.1 Market Overview

12.1.1 Market Size and Forecast

13. Global Mass Spectrometry Reagents

Market

13.1 Market Overview

13.1.1 Market Size and Forecast

14. Global Electrophoresis Reagents Market

14.1 Market Overview

14.1.1 Market Size and Forecast

15. Geographical Segmentation

16. Key Leading Countries

16.1 US

16.2 Biotechnology Reagents Market in the US

16.2.1 Market Size and Forecast

16.3 Germany

16.4 Biotechnology Reagents Market in Germany

16.4.1 Market Size and Forecast

16.5 Japan

16.6 Biotechnology Reagents Market in Japan

16.6.1 Market Size and Forecast

17. Buying Criteria

18. Market Growth Drivers

19. Drivers and their Impact

20. Market Challenges

21. Impact of Drivers and Challenges

22. Market Trends

23. Trends and their Impact

24. Vendor Landscape

24.1 Competitive Scenario

24.1.1 Key News

24.1.2 Mergers and Acquisitions

24.2 Market Share Analysis 2013

24.3 Other Prominent Vendors

25. Key Vendor Analysis

25.1 Agilent Technologies

25.1.1 Key Facts

25.1.2 Business Overview

25.1.3 Business Segmentation by Revenue 2013

25.1.4 Business Segmentation by Revenue 2012 and 2013

25.1.5 Geographical Segmentation by Revenue 2013

25.1.6 Business Strategy

25.1.7 Recent Developments

25.1.8 SWOT Analysis

25.2 BD

25.2.1 Key Facts

25.2.2 Business Overview

25.2.3 Business Segmentation

25.2.4 Business Segmentation by Revenue

25.2.5 Business Segmentation by Revenue 2012 and 2013

25.2.6 Geographical Segmentation by Revenue 2013

25.2.7 Business Strategy

25.2.8 Key Developments

25.2.9 SWOT Analysis

25.3 Bio-Rad

25.3.1 Key Facts

25.3.2 Business Overview

25.3.3 Business Segmentation

25.3.4 Business Strategy

25.3.5 Business Segmentation by Revenue

25.3.6 Business Segmentation by Revenue 2011 and 2012

25.3.7 Geographical Segmentation by Revenue 2012

25.3.8 Key Developments

25.3.9 SWOT Analysis

25.4 F. Hoffmann-La Roche

25.4.1 Key Facts

25.4.2 Business Overview

25.4.3 Business Segmentation by Revenue 2013

25.4.4 Business Segmentation by Revenue 2012 and 2013

25.4.5 Geographical Segmentation by Revenue 2013

25.4.6 Business Strategy

25.4.7 Recent Developments

25.4.8 SWOT Analysis

25.5 Sigma-Aldrich

25.5.1 Key Facts

25.5.2 Business Overview

25.5.3 Business Segmentation

25.5.4 Business Strategy

25.5.5 Business Segmentation by Revenue

25.5.6 Sales by Geography

25.5.7 Key Developments

25.5.8 SWOT Analysis

25.6 Thermo Fisher

25.6.1 Key Facts

25.6.2 Business Overview

25.6.3 Business Segmentation

25.6.4 Business Segmentation by Revenue

25.6.5 Product Segmentation by Revenue

25.6.6 Geographical Segmentation by Revenue 2013

25.6.7 Business Strategy

25.6.8 Key Information

25.6.9 SWOT Analysis

26. Other Reports in this Series